Abstract S11-02: Factors associated with developing COVID-19 among cancer patients in New York City

2021 ◽  
Author(s):  
Monica F. Chen ◽  
Monica T. Coronel ◽  
Samuel Pan ◽  
Arreum Kim ◽  
Jessica Hawley ◽  
...  
Keyword(s):  
New York ◽  
New York City ◽  
Cancer Patients ◽  
York City ◽  
Factors Associated

Outcomes for hospitalized cancer patients with COVID-19 during the height of pandemic in New York City.

2021 ◽  
Vol 39 (15_suppl) ◽  
pp. 10572-10572
Author(s):  
Amelia Sawyers ◽  
Margaret Chou ◽  
Paul Johannet ◽  
Nicholas Gulati ◽  
Yingzhi Qian ◽  
...  
Keyword(s):  
New York ◽  
New York City ◽  
Cancer Patients ◽  
York City ◽  
Measurable Disease ◽  
All Cause Mortality ◽  
History Of ◽  
The Impact ◽  
History Of Cancer ◽  
Active Cancer

10572 Background: Several reports have suggested that cancer patients are at increased risk for contracting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and suffering worse coronavirus disease 2019 (COVID-19) outcomes. However, little is known about the impact of cancer status on presentation and outcome. Here, we report on the association between cancer status and survival in hospitalized patients who tested positive for SARS-CoV-2 during the height of pandemic in New York City. Methods: Of the 6,724 patients who were hospitalized at NYU Langone Health (3/16/20 - 7/31/20) and tested positive for SARS-CoV-2, 580 had either active cancer (n = 221) or a history of cancer (n = 359). Patients were classified as having active malignancy if they either received treatment within six months of their COVID-19 diagnosis or they had measurable disease documented at the time of their hospitalization. Patients were categorized as having a history of cancer if there was no evidence of measurable disease or there were no treatments administered within six months of their COVID-19 diagnosis. We compared the baseline clinicodemographic characteristics and hospital courses of the two groups, and the relationship between cancer status and the rate of admission to the intensive care unit (ICU), use of invasive mechanical ventilation (IMV), and all-cause mortality. Results: There was no differences between the two groups in their baseline laboratory results associated with COVID-19 infection, incidence of venous thromboembolism, or incidence of severe COVID-19. Active cancer status was not associated with the rate of ICU admission ( P = 0.307) or use of IMV ( P = 0.236), but was significantly associated with worse all-cause mortality in both univariate and multivariate analysis with ORs of 1.48 (95% CI: 1.04-2.09; P = 0.028) and 1.71 (95% CI: 1.12-2.63; P = 0.014), respectively. Conclusions: Active cancer patients had worse survival outcomes compared to patients with a history of cancer despite similar COVID-19 disease characteristics in the two groups. Our data suggest that cancer care should continue with minimal interruptions during the pandemic to bring about response and remission as soon as possible. Additionally, these findings support the growing body of evidence that malignancy portends worse COVID-19 prognosis, and demonstrate that the risk may even apply to those without active disease.

Dental Caries Experience, Tooth Loss, and Factors Associated with Unmet Needs of Haitian Immigrants in New York City

2001 ◽  
Vol 61 (4) ◽  
pp. 203-209 ◽  
Author(s):  
Gustavo D. Cruz ◽  
Xiaonan Xue ◽  
Racquel Z. LeGeros ◽  
Nandor Halpert ◽  
Diana L. Galvis ◽  
...  
Keyword(s):  
New York ◽  
New York City ◽  
Dental Caries ◽  
York City ◽  
Tooth Loss ◽  
Unmet Needs ◽  
Caries Experience ◽  
Haitian Immigrants ◽  
Factors Associated

Incidence and risk factors for community-associated methicillin-resistant Staphylococcus aureus in New York City, 2006–2012

2015 ◽  
Vol 144 (5) ◽  
pp. 1014-1017 ◽  
Author(s):  
P. BAKER ◽  
B. COHEN ◽  
J. LIU ◽  
E. LARSON
Keyword(s):  
Risk Factors ◽  
New York ◽  
Staphylococcus Aureus ◽  
New York City ◽  
Logistic Regression ◽  
York City ◽  
Methicillin Resistant Staphylococcus Aureus ◽  
Methicillin Resistant ◽  
Factors Associated ◽  
History Of

SUMMARYThis study aims to describe changes in incidence and risk factors for community-associated methicillin resistant Staphylococcus aureus (CA-MRSA) infections upon admission to two New York City hospitals from 2006 to 2012. We examined the first hospitalization for adult patients using electronic health record and administrative data and determined the annual incidence/1000 admissions of total S. aureus, total MRSA, and CA-MRSA (within 48 h of admission) in clinical specimens over the study period. Logistic regression was used to identify factors associated with CA-MRSA in 2006 and 2012. In 137 350 admissions, the incidence of S. aureus, MRSA, and CA-MRSA/1000 admissions were 15·6, 7·0, and 3·5, respectively. The total S. aureus and MRSA isolations decreased significantly over the study period (27% and 25%, respectively) while CA-MRSA incidence was unchanged. CA-MRSA increased as a proportion of all MRSA between 2006 (46%) and 2012 (62%), and was most frequently isolated from respiratory (1·5/1000) and blood (0·7/1000) cultures. Logistic regression analysis of factors associated with isolation of CA-MRSA showed that age ⩾65 years [odds ratio (OR) 2·3, 95% confidence interval (CI) 1·2–4·5], male gender (OR 1·8, 95% CI 1·2–2·8) and history of renal failure (OR 2·6, 95% CI 1·6–4·2) were significant predictors of infection in 2006. No predictors were identified in 2012.

scholarly journals Hospital-level factors associated with death during pneumonia-associated hospitalization among adults—New York City, 2010–2014

PLoS ONE ◽  
2021 ◽  
Vol 16 (10) ◽  
pp. e0256678
Author(s):  
Kate Whittemore ◽  
Kristian M. Garcia ◽  
Chaorui C. Huang ◽  
Sungwoo Lim ◽  
Demetre C. Daskalakis ◽  
...  
Keyword(s):  
New York ◽  
New York City ◽  
York City ◽  
Death Rate ◽  
Teaching Hospitals ◽  
Hospital Death ◽  
Negative Binomial Regression Model ◽  
Hospital Level ◽  
American Hospital ◽  
Factors Associated

Background In New York City (NYC), pneumonia is a leading cause of death and most pneumonia deaths occur in hospitals. Whether the pneumonia death rate in NYC reflects reporting artifact or is associated with factors during pneumonia-associated hospitalization (PAH) is unknown. We aimed to identify hospital-level factors associated with higher than expected in-hospital pneumonia death rates among adults in NYC. Methods Data from January 1, 2010–December 31, 2014 were obtained from the New York Statewide Planning and Research Cooperative System and the American Hospital Association Database. In-hospital pneumonia standardized mortality ratio (SMR) was calculated for each hospital as observed PAH death rate divided by expected PAH death rate. To determine hospital-level factors associated with higher in-hospital pneumonia SMR, we fit a hospital-level multivariable negative binomial regression model. Results Of 148,172 PAH among adult NYC residents in 39 hospitals during 2010–2014, 20,820 (14.06%) resulted in in-hospital death. In-hospital pneumonia SMRs varied across NYC hospitals (0.77–1.23) after controlling for patient-level factors. An increase in average daily occupancy and membership in the Council of Teaching Hospitals were associated with increased in-hospital pneumonia SMR. Conclusions Differences in in-hospital pneumonia SMRs between hospitals might reflect differences in disease severity, quality of care, or coding practices. More research is needed to understand the association between average daily occupancy and in-hospital pneumonia SMR. Additional pneumonia-specific training at teaching hospitals can be considered to address higher in-hospital pneumonia SMR in teaching hospitals.

scholarly journals Factors Associated with SARS-CoV-2 Infection in Physician Trainees in New York City During the First COVID-19 Wave

2021 ◽  
Vol 4 (2) ◽  
Author(s):  
Kate R. Pawloski ◽  
Betty Kolod ◽  
Rabeea F. Khan ◽  
Vishal Midya ◽  
Tania Chen ◽  
...  
Keyword(s):  
New York ◽  
New York City ◽  
York City ◽  
Factors Associated

scholarly journals Dynamic Management of Lung Cancer Care During Surging COVID-19

2021 ◽  
Vol 8 ◽  
Author(s):  
Annie Wang ◽  
Stephanie H. Chang ◽  
Eric J. Kim ◽  
Jamie L. Bessich ◽  
Joshua K. Sabari ◽  
...  
Keyword(s):  
Lung Cancer ◽  
New York ◽  
New York City ◽  
Cancer Patients ◽  
York City ◽  
Healthcare Workers ◽  
New York University ◽  
Lung Cancer Patients ◽  
Increased Risk ◽  
Review Current

Management of patients with lung cancer continues to be challenging during the COVID-19 pandemic, due to the increased risk of complications in this subset of patients. During the COVID-19 surge in New York City, New York University Langone Health adopted triage strategies to help with care for lung cancer patients, with good surgical outcomes and no transmission of COVID-19 to patients or healthcare workers. Here, we will review current recommendations regarding screening and management of lung cancer patients during both a non-surge phase and surge phase of COVID-19.

Sign in / Sign up

Export Citation Format

Share Document